ArticleFrontiers in pediatrics2025
Associations between demographic and disease related factors and anxiety and depression among adolescents with chronic kidney disease.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the current status of comorbid anxiety and depression in adolescents with chronic kidney disease and to analyze their associated factors. Methods: 105 adolescents with chronic kidney disease, hospitalized in the First Affiliated Hospital of Henan University of Traditional Chinese Medicine from May 2022 to May 2023, were selected through convenience sampling. A general information questionnaire, anxiety self-assessment scale, and depression self-assessment scale were used. Factors associated with anxiety and depression were analyzed using univariate analysis, and significant variables underwent multinomial logistic regression. Results: Among the 105 adolescents, 11 cases (10.5%) had anxiety alone, 6 cases (5.7%) had depression alone, and 26 cases (24.8%) presented both anxiety and depression. Multinomia logistic regression analysis revealed that the illness duration (>12 months) (OR = 34.114), duration of hormone treatment (≥12 months) (OR = 37.585), duration of immunotherapy (≥12 months) (OR = 12.700), and OR values greater than 1 indicate that illness duration (>12 months), duration of hormone treatment (≥12 months), and the duration of immunotherapy (≥12 months) are independent associated factors for nanxiety and depression. Conclusion: In this cross-sectional cohort study, the illness duration, duration of hormone treatment and duration of immunotherapy are independent associated factors for anxiety and depression. Psychological screening should be prioritized for adolescents with these clinical features, and relevant measures should be taken to reduce the incidence of anxiety and depression in adolescents with CKD. Future longitudinal studies could begin by elucidating whether modifying treatment can reduce mental health risks, taking into account potential bidirectional effects between disease control and mental health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.